ISPACOS visited the Japan Pharmaceutical Association on August 5, 2019, and the Japanese Society of Hospital Pharmacists on November 6, 2019, to submit a request titled “Considerations in Medication Guidance for Olaparib.” Following this request, both organizations issued a notice on February 21, 2020, calling for greater attention to appropriate considerations when providing medication guidance […]

On November 6, 2019, ISPACOS visited the Japanese Society of Hospital Pharmacists and submitted a request titled “Considerations in Medication Guidance for Olaparib.” Through this request, ISPACOS expressed its hope that stronger collaboration between hospitals and community pharmacies will help to ensure that medication guidance for patients is provided with appropriate care and consideration.